Citation Impact
Citing Papers
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
2013 Standout
Reduction in the Incidence of Type 2 Diabetes With the Mediterranean Diet
2010 Standout
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
2012 Standout
Interventions to improve antibiotic prescribing practices for hospital inpatients
2017 Standout
Anaesthesia, surgery, and challenges in postoperative recovery
2003 Standout
Molecular mediators of hepatic steatosis and liver injury
2004 Standout
MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity
2006 Standout
Prostaglandin synthase 1 gene disruption in mice reduces arachidonic acid-induced inflammation and indomethacin-induced gastric ulceration
1995 StandoutNobel
Physicochemical and Physiological Mechanisms for the Effects of Food on Drug Absorption: The Role of Lipids and pH
1997
The Role of β-Glucuronidase in Drug Disposition and Drug Targeting in Humans
1997
Increased oxidative stress in obesity and its impact on metabolic syndrome
2004 Standout
Prevention of Type II diabetes in subjects with impaired glucose tolerance: the Diabetes Prevention Study (DPS) in Finland
1999
Diagnosis and Treatment of Low Back Pain: A Joint Clinical Practice Guideline from the American College of Physicians and the American Pain Society
2007 Standout
Interactions Between Glucose and FFA Metabolism in Man
1996
Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension
2010 Standout
Hallmarks of aging: An expanding universe
2023 Standout
A human whole blood assay for clinical evaluation of biochemical efficacy of cyclooxygenase inhibitors
1996
Analgesics in Patients with Hepatic Impairment
2012
Oral Antihyperglycemic Therapy for Type 2 Diabetes
2002
Influencing Prescribing for Urinary Tract Infection and Asthma in Primary Care in Sweden
1999
Reducing prescribing of highly anticholinergic antidepressants for elderly people: randomised trial of group versus individual academic detailing
2001
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs
2007 Standout
The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study
2008
In vitro assessment of oral lipid based formulations
2001
Interventions to improve antibiotic prescribing practices for hospital inpatients
2013 Standout
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
2015 Standout
Understanding the mechanisms and drivers of antimicrobial resistance
2015 Standout
Diabetes Prevention Programs
2011
Risk for Serious Gastrointestinal Complications Related to Use of Nonsteroidal Anti-inflammatory Drugs
1991 Standout
Nonsteroidal Antiinflammatory Drugs — Differences and Similarities
1991
The relationship between dysglycaemia and cardiovascular and renal risk in diabetic and non-diabetic participants in the HOPE study: a prospective epidemiological analysis
2005
Polyphenols: food sources and bioavailability
2004 Standout
Prevalence of Diabetes among Men and Women in China
2010 Standout
Treatment of Hypertension in Patients 80 Years of Age or Older
2008 Standout
Comparative effect of paracetamol, NSAIDs or their combination in postoperative pain management: a qualitative review
2002
Aminotransferase Elevations in Healthy Adults Receiving 4 Grams of Acetaminophen Daily
2006
NAD+ homeostasis in health and disease
2020
Appropriate prescribing in elderly people: how well can it be measured and optimised?
2007 Standout
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2012 Standout
Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study
2014
Cyclodextrin-based pharmaceutics: past, present and future
2004 Standout
Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse
1995 StandoutNobel
Oral administration of rac-α-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: a placebo-controlled pilot trial
1999
Appropriateness in health care: Application to prescribing
1997
Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose Tolerance
2001 Standout
No excess 12-year mortality in men with impaired glucose tolerance who participated in the Malm� Preventive Trial with diet and exercise
1998
Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition
2019 Standout
Prediabetes: a high-risk state for diabetes development
2012 Standout
NONSTEROIDAL ANTI-INFLAMMATORY DRUGS ANOTHER LOOK
1988
Use and Benefits of Nonsteroidal Anti-inflammatory Drugs
1998
Prediction of Cardiovascular Events and All-Cause Mortality With Arterial Stiffness
2010 Standout
The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
2005 Standout
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
2013 Standout
From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus
2009 Standout
Audit and feedback: effects on professional practice and healthcare outcomes
2012 Standout
Diabetic Nephropathy: Diagnosis, Prevention, and Treatment
2005 Standout
Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy
2008 Standout
Comparison of Five In Vitro Digestion Models To Study the Bioaccessibility of Soil Contaminants
2002 Standout
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial
2010 Standout
Prevention Conference VI: Diabetes and Cardiovascular Disease
2002
Effect of a Sustained Reduction in Plasma Free Fatty Acid Concentration on Intramuscular Long-Chain Fatty Acyl-CoAs and Insulin Action in Type 2 Diabetic Patients
2005
Prevention of diabetes and reduction in major cardiovascular events in studies of subjects with prediabetes: meta-analysis of randomised controlled clinical trials
2011
Meta-Analysis: Glycosylated Hemoglobin and Cardiovascular Disease in Diabetes Mellitus
2004 Standout
Oxidative Stress and Diabetic Complications
2010 Standout
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
2006 Standout
Interventions to improve antibiotic prescribing practices in ambulatory care
2005
Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes
2002 Standout
Postchallenge Hyperglycemia and Mortality in a National Sample of U.S. Adults
2001
Disordered Fat Storage and Mobilization in the Pathogenesis of Insulin Resistance and Type 2 Diabetes
2002
Identification of palmitoylated mitochondrial proteins using a bio‐orthogonal azido‐palmitate analogue
2007 StandoutNobel
CYCLOOXYGENASES 1 AND 2
1998 StandoutNobel
Mechanisms of Diabetic Complications
2013 Standout
Interactions Between Glucose and FFA Metabolism in Man
1996
β-Cell Failure in Diabetes and Preservation by Clinical Treatment
2007
The Metabolic Syndrome
2008 Standout
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Effects of Intensive Glucose Lowering in Type 2 Diabetes
2008 Standout
Diabetic Autonomic Neuropathy
2003 Standout
Effects of Metformin in Patients with Poorly Controlled, Insulin-Treated Type 2 Diabetes Mellitus
1999
Impaired Autonomic Function Is Associated With Increased Mortality, Especially in Subjects With Diabetes, Hypertension, or a History of Cardiovascular Disease
2001
Prevention Conference VI: Diabetes and Cardiovascular Disease
2002
Works of A. Melander being referenced
EQUIANALGESIC EFFECTS OF PARACETAMOL AND INDOMETHACIN IN RHEUMATOID ARTHRITIS
1988
Clinical pharmacology and primary health care in Europe ? a gap to bridge
1990
Glucose tolerance and mortality, including a substudy of tolbutamide treatment
1997
Glycaemic control, disease duration and β‐cell function in patients with Type 2 diabetes in a Swedish community. Skaraborg Hypertension and Diabetes Project
2002
Drug prescription attitudes and behaviour of general practitioners
1995
Impaired glucose metabolism and obesity in Swedish patients with borderline isolated systolic hypertension: Skaraborg Hypertension and Diabetes Project
2001
Reduction of Paracetamol and Aspirin Metabolism During Viral Hepatitis
1986
Pronounced blood glucose-lowering effect of the antilipolytic drug acipimox in noninsulin-dependent diabetes mellitus patients during a 3-day intensified treatment period.
1994
Influence of renal failure, rheumatoid arthritis and old age on the pharmacokinetics of diflunisal
1989
Therapeutic Comparison of Metformin and Sulfonylurea, Alone and in Various Combinations. A Double-Blind Controlled Study
1995
Oral Antidiabetic Drugs: an Overview
1996
Food intake and drug bioavailability.
1981
Influence of Food and Different Nutrients on Drug Bioavailability1
2015